Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Transitional Cell × Surgical Procedures, Operative × 30 days × Clear all

Sponsor

Conditions

Lung Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Squamous Cell Carcinoma of Head and Neck 2 Recurrence 2 Neoplasms 2 Mouth Neoplasms 2 Glioblastoma 2 Colorectal Neoplasms 2 Brain Neoplasms 2 Wilms Tumor 1 Thyroid Neoplasms 1 Sinonasal Squamous Cell Carcinoma 1 Sarcoma 1 Rectal Neoplasms 1 Pilonidal Sinus 1 Oropharyngeal Neoplasms 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Nasopharyngeal Carcinoma 1 Melanoma 1 Liposarcoma 1 Leiomyosarcoma 1 Laryngeal Neoplasms 1 Hypopharyngeal Neoplasms 1 Hepatic Veno-Occlusive Disease 1 Head and Neck Neoplasms 1 HER2-positive Early Breast Cancer 1 Glioma 1 Germinoma 1 Eyelid Squamous Cell Carcinoma 1 Ependymoma 1

Interventions

pembrolizumab 14 enfortumab vedotin 10 Specimen Handling 8 Magnetic Resonance Spectroscopy 8 Nivolumab 7 Carboplatin 5 avelumab 4 Ipilimumab 4 Cisplatin 4 Gemcitabine 3 Docetaxel 3 sacituzumab govitecan 2 cabozantinib 2 atezolizumab 2 Paclitaxel 2 CTLA-4 Antigen 2 Biopsy 2 zimberelimab 1 zanidatamab 1 tazemetostat 1 soluble LAG-3 protein, human 1 sargramostim 1 sapanisertib 1 relatlimab 1 regorafenib 1 lenvatinib 1 erdafitinib 1 durvalumab 1 dodecyl maltoside 1 darolutamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡